Literature DB >> 3742494

Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.

R E Slayton, J A Blessing, F B Stehman, J Malfetano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3742494

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

Review 1.  Chemotherapy for advanced or recurrent carcinoma of the cervix.

Authors:  J D Bloss
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

2.  A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.

Authors:  R E Slayton; J A Blessing; M Rettenmaier; H Ball
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.